Within the Uppsala 95 cohort, PD-L1 amplification was detected in 10 (4.5%) and polysomy in 3 (1.3%) out of the 224 evaluable NSCLC cases (Supplementary Fig. 2A). This evidence concerns the gene CD274 and non-small cell lung carcinoma.